Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sarcoma, Synovial × pasireotide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 3 Nelson Syndrome 2 Carcinoid Tumor 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Serotonin Syndrome 1 Sarcoma, Synovial 1 Prostatic Neoplasms 1 Prolactin-Producing Pituitary Tumor 1 Primary Inoperable Thymoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pituitary ACTH Hypersecretion 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Meningioma 1 Lymphoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Hematologic Neoplasms 1 Growth Disorders 1 Gigantism 1 Desmoplastic Small Round Cell Tumor 1 Carcinoma, Neuroendocrine 1

Interventions

Gemcitabine 3 Doxorubicin 3 pembrolizumab 2 pazopanib 2 fludarabine 2 cixutumumab 2 brostallicin 2 Sorafenib 2 Docetaxel 2 Cyclophosphamide 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 tremelimumab 1 tazemetostat 1 sotigalimab 1 soblidotin 1 reolysin 1 perifosine 1 pasireotide 1 lorvotuzumab mertansine 1 ixabepilone 1 interferon gamma-1b 1 exatecan 1 durvalumab 1 drozitumab 1 atezolizumab 1 Trastuzumab 1 Trabectedin 1 Temozolomide 1 Surgical Procedures, Operative 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06456359 2025-01-13

PAMSARC

University Hospital Heidelberg

Phase 2 Recruiting

Sarcoma, Synovial, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡